Urinary incontinence in women

Overview

Urinary incontinence is any involuntary leakage of urine. It is a symptom, not a diagnosis — the diagnosis is the mechanism behind it. The EPIC population survey across five countries found 64.3% of adults reported at least one lower urinary tract symptom, with overall urinary incontinence at 9.4% and overactive bladder at 11.8%.^[2] Worldwide modelling projects 423 million people with urinary incontinence, a 21.6% increase over a decade.^[5]

The defining general practice statistic is not prevalence but silence. In the Norwegian EPINCONT study, only 26% of incontinent women had ever seen a doctor about it; even among women with significant, troublesome incontinence, only half had consulted.^[1] Among young women aged 22–27, 11% reported incontinence in the past month, and only one in five had sought help.^[9] The condition also costs working women directly: symptom severity predicts workplace productivity impairment, yet 60% of affected working women had never contacted a doctor and 72.7% had never been treated.^[23]

References32ShowHide

1. [1]Hannestad YS, Rortveit G, Hunskaar S Help-seeking and associated factors in female urinary incontinence. The Norwegian EPINCONT Study. Epidemiology of Incontinence in the County of Nord-Trøndelag Scand J Prim Health Care, 2002.PMID 12184708
2. [2]Irwin DE, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study Eur Urol, 2006.PMID 17049716
3. [3]Subak LL, et al. Weight loss to treat urinary incontinence in overweight and obese women N Engl J Med, 2009.PMID 19179316
4. [4]Hashim H, Al Mousa R Management of fluid intake in patients with overactive bladder Curr Urol Rep, 2009.PMID 19863853
5. [5]Irwin DE, et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction BJU Int, 2011.PMID 21231991
6. [6]Visco AG, et al. Adherence to Oral Therapy for Urgency Urinary Incontinence: Results from the Anticholinergic Versus Botox Comparison (ABC) Trial Female Pelvic Med Reconstr Surg, 2016.PMID 26516810
7. [7]Moyson J, et al. [Efficacy and safety of available therapies in the management of idiopathic overactive bladder: A systematic review of the literature] Prog Urol, 2017.PMID 28228331
8. [8]Araujo CC, Marques AA, Juliato CRT The Adherence of Home Pelvic Floor Muscles Training Using a Mobile Device Application for Women With Urinary Incontinence: A Randomized Controlled Trial Female Pelvic Med Reconstr Surg, 2020.PMID 30624250
9. [9]Lamerton TJ, Mielke GI, Brown WJ Urinary incontinence in young women: Risk factors, management strategies, help-seeking behavior, and perceptions about bladder control Neurourol Urodyn, 2020.PMID 32805080
10. [10]Keyser LE, et al. A digital health program for treatment of urinary incontinence: retrospective review of real-world user data Int Urogynecol J, 2023.PMID 35969249
11. [11]Kennelly M, et al. Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis Drugs Context, 2022.PMID 36303599
12. [12]Kakkar A, et al. Adverse events associated with pessary use over one year among women attending a pessary care clinic Int Urogynecol J, 2023.PMID 36715742
13. [13]Park J, et al. Effectiveness of Fluid and Caffeine Modifications on Symptoms in Adults With Overactive Bladder: A Systematic Review Int Neurourol J, 2023.PMID 37015722
14. [14]Vasudeva P, et al. Autologous versus synthetic midurethral transobturator sling: A systematic review and meta-analysis of outcomes Neurourol Urodyn, 2024.PMID 38873955
15. [15]Hall E, et al. Real-World Evidence From a Digital Health Treatment Program for Female Urinary Incontinence: Observational Study of Outcomes Following User-Centered Product Design JMIR Form Res, 2024.PMID 38935967
16. [16]Kaga K, Mikami K, Kaga M Utilizing Bladder Diaries to Prevent Unnecessary Treatment in Patients With Storage Dysfunction: A Retrospective Study Cureus, 2024.PMID 39360064
17. [17]MacArthur C, et al. Antenatal pelvic floor muscle exercise intervention led by midwives in England to reduce postnatal urinary incontinence: APPEAL feasibility and pilot randomised controlled cluster trial BMJ Open, 2025.PMID 39832969
18. [18]Fernandes ACN, et al. Pelvic floor muscle training with feedback or biofeedback for urinary incontinence in women Cochrane Database Syst Rev, 2025.PMID 40066950
19. [19]Thuillier C, et al. Why should we stop implanting transobturator sling? Fr J Urol, 2025.PMID 40250730
20. [20]Cassé A, et al. State of knowledge on the specialized management of urinary incontinence and pelvic organ prolapse among general practitioners in Western France in the current mesh controversy era Fr J Urol, 2025.PMID 40447261
21. [21]Getaneh FW, Sussman RD, Iglesia CB Nocturia: Evaluation and Management Am Fam Physician, 2025.PMID 40531150
22. [22]Porcari I, et al. Vulvovaginal estrogen therapy for urinary symptoms in postmenopausal women: a review and meta-analysis Climacteric, 2026.PMID 40569036
23. [23]Porto MG, et al. Urinary incontinence severity: the impact on workplace productivity World J Urol, 2025.PMID 40646280
24. [24]Hasan M, et al. Long-Term Outcomes and Recurrence Rates of TVT versus TVTO in Female Stress Urinary Incontinence: A Systematic Review of Studies with ≥5-Year Follow-Up Int Urogynecol J, 2025.PMID 40844543
25. [25]Vesentini G, et al. Interventions for treating urinary incontinence in older women: a network meta-analysis Cochrane Database Syst Rev, 2025.PMID 41307301
26. [26]Banerjee I, et al. Quality and associated factors of guideline-concordant primary care referral for urinary incontinence and pelvic organ prolapse: A single centre retrospective observational study Eur J Obstet Gynecol Reprod Biol, 2026.PMID 41849977
27. [27]Trikhacheva AS, et al. IncobotulinumtoxinA Versus OnabotulinumtoxinA for Treatment of Overactive Bladder Syndrome: A Randomized Single-blinded Non-inferiority Trial Urology, 2026.PMID 41933558
28. [28]Liu J, et al. Electromyographic biofeedback-assisted pelvic floor muscle training for female stress urinary incontinence: a systematic review and meta-analysis Front Med (Lausanne), 2026.PMID 42445160
29. [29]Mohamed-Ahmed R, Rantell A, Robinson D Comparing the safety and efficacy of vibegron, mirabegron and tolterodine in patients with overactive bladder: a systematic review and network meta-analysis Eur J Obstet Gynecol Reprod Biol, 2026.PMID 42501511
30. [30]Salman MFA, et al. Autologous Transobturator Fascia Lata Sling for Female Stress Urinary Incontinence: A Pilot Feasibility and Safety Study Low Urin Tract Symptoms, 2026.PMID 42521462
31. [31]Sangsawi P, Aree-Ue S, Roopsawang I Exploring the Link of Psychological Adaptation, Socio-Economic Status, and Symptom Types on Quality of Life in Community-Dwelling Older Women With Lower Urinary Tract Symptoms J Prim Care Community Health, 2026.PMID 42526051
32. [32]Kaya H, et al. Effect of Second Sling Type on the Success of Repeat Procedures Urogynecology (Phila), 2026.PMID 42593896